Shareholder plans Rule 144 sale of 5,160 TNYA shares

A shareholder filed a notice to sell 5,160 shares of common stock under Rule 144 through Morgan Stanley Smith Barney on or about February 17, 2026.

Rhea-AI Filing Summary

A shareholder filed a notice to sell 5,160 shares of common stock under Rule 144 through Morgan Stanley Smith Barney on or about February 17, 2026. The shares have an aggregate market value of $3,318.72 and are listed on the Nasdaq Global Select Market.

The securities relate to common stock acquired on February 17, 2026 via a restricted stock unit grant from the issuer, totaling 13,750 shares. The issuer reports 213,744,535 shares of this class outstanding, providing context for the size of the planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TNYA Form 144 filing disclose about planned share sales?

The filing discloses a planned Rule 144 sale of 5,160 shares of common stock with an aggregate market value of $3,318.72. The shares are to be sold through Morgan Stanley Smith Barney on the Nasdaq Global Select Market.

How many TNYA shares are outstanding compared to the amount being sold?

The issuer reports 213,744,535 shares of common stock outstanding. The planned Rule 144 sale covers 5,160 shares, which is a very small fraction of the total outstanding, indicating a limited relative size for this specific transaction.

How were the TNYA shares in the Form 144 acquired?

The common stock referenced in the notice was acquired on February 17, 2026 via a restricted stock unit transaction from the issuer. On that date, the person obtained 13,750 shares, of which a portion is now planned for resale.

Which broker will handle the TNYA Rule 144 share sale?

The planned sale will be executed through Morgan Stanley Smith Barney, specifically its Operations Department located at 2000 Westchester Ave, Purchase, NY 10577-2530. The filing also notes that the shares are traded on the Nasdaq Global Select Market.

What assurance does the seller give about information on TNYA?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is part of the standard certification included in the Rule 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:09 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001868494
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Tenaya Therapeutics, Inc.
SEC File Number	001-40656
Address of Issuer	171 Oyster Point Boulevard Suite 500 South San Francisco CALIFORNIA 94080
Phone	(650)-825-6990
Name of Person for Whose Account the Securities are To Be Sold	Whittemore Tingley
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney Operations Department 2000 Westchester Ave Purchase NY 10577-2530	5160	3318.72	213744535	02/17/2026	Nasdaq Global Select

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/17/2026	Restricted Stock Unit	Issuer			13750	02/17/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Whittemore Tingley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)